Alcon, the multinational pharmaceuticals company specializing in eye care, has agreed a deal to acquire cataract laser ...

Refractive cataract surgery has been transformed by advanced IOL technology, including extended and full-range vision lenses, ...

Alcon announced today that it entered into a definitive merger agreement through which it intends to acquire Lensar.

Alcon will expand its femtosecond laser-assisted cataract surgery offerings with a deal to acquire Lensar, according to a ...

The acquisition will include Lensar’s ALLY Robotic Cataract Laser Treatment System and Streamline software technology.

Medically reviewed by Christine L. Larsen, MD A cataract (cloudy eye lens) blocks light from reaching the retina, which helps ...

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser ...

From persistent dry eyes to unexpected complications – what experts say you should know before undergoing Lasik surgery.

Alcon enters into a definitive merger agreement to acquire LENSAR's ALLY Robotic Cataract Laser Treatment System, proprietary ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and LENSAR, Inc. (NASDAQ: LNSR), a global medical technology company focused on advanced laser ...

In a strategic push to cement its dominance in ophthalmic technology, Alcon Inc. has inked a $430 million agreement to acquire Lensar Inc., a Florida-based innovator in laser-assisted cataract surgery ...